UHMS Las Vegas: Rossignol Autism Study Presented

Dr Dan Rossignol acquitted himself well today in presenting his BMC Pediatrics paper (see our March 13 post) to a packed house. Though he claimed no new knowledge of HBOT's possible mechanisms of action in children with autism, he observed interesting connections between cerebral hypoperfusion and neuroinflammation, with marked reductions in C-reactive protein, and between Clostridia bacteria and Crohn's-like lesions in the intestine. Effectively anticipating argument, placing his work in proper context, and calling for others to replicate and expand upon his research, Rossignol surely won more than a few new supporters and future investigators.